[Studies on a possibility of clinical utilization of the synnergism between cycloserine and other antibiotics in the treatment of infections caused by staphylococci resistant to penicillin. Communication 2].
D000900:Anti-Bacterial Agents / Q000628:therapy*; D000904:Antibiotics, Antitubercular; D003142:Communication; D003523:Cycloserine / Q000628:therapy*; D003879:Dermatologic Agents; D006801:Humans; D010406:Penicillins; D013203:Staphylococcal Infections / Q000628:therapy*; D013210:Staphylococcus
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D003879:Dermatologic Agents; D010406:Penicillins; D003523:Cycloserine
ANTIBIOTICS/therapy; CYCLOSERINE/therapy; STAPHYLOCOCCAL INFECTIONS/therapy